Weyerhaeuser Company
—- Market cap
- —
- Debt
- —
- Cash
- −$464.00M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: WY stock price vs CSGP: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CSGP's multiple
Needs CSGP P/E.
Implied fair value · at WY's multiple
Needs WY P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
WEYERHAEUSER COMPANY · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
COSTAR GROUP, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
RAYONIER INC
WY vs RYN
POTLATCHDELTIC CORP
WY vs PCH
INTERNATIONAL PAPER CO /NEW/
WY vs IP
UFP INDUSTRIES INC
WY vs UFPI
VORNADO REALTY TRUST
WY vs VNO
WELLTOWER INC.
WY vs WELL
Prologis, Inc.
WY vs PLD
Public Storage
WY vs PSA
EQUITY RESIDENTIAL
WY vs EQR
CROWN CASTLE INC.
WY vs CCI
CENTERSPACE
WY vs CSR
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe WY can reaccelerate earnings growth while holding margins and capital returns near current levels, then wait for a better entry or use only a cautious position, because the stock already sits above the DCF range and near the top of its historical band despite only middling quality scores.
The indicated CSGP-implied value of $665.55 is far above WY's current price of $25.45, but that gap is not economically credible because CSGP trades at an exceptionally stretched 1479.0x P/E. By contrast, WY sits inside its historical band and far above its DCF range, suggesting the stock is expensive on intrinsic value despite not looking cheap versus CSGP screen.
Supporting Metrics